The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In Vitro Diagnostics (IVD)-Global Market Insights and Sales Trends 2025
Synopsis
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
The global In Vitro Diagnostics (IVD) market size is expected to reach US$ 1530.1 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Diagnostics (IVD) in various end use industries. The expanding demands from the Standalone Laboratory, Hospitals, Academic and Medical Schools and Point of Care Testing, are propelling In Vitro Diagnostics (IVD) market. Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Diagnostics (IVD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Diagnostics (IVD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Diagnostics (IVD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Diagnostics (IVD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Diagnostics (IVD) covered in this report include Pfizer, Thermo Fisher Scientific, Abbott, Biomerieux, Danaher Corporation, F. Hoffmann-La Roche, Becton Dickinson and Company, Bio-Rad Laboratories and Bayer AG, etc.
The global In Vitro Diagnostics (IVD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Thermo Fisher Scientific
Abbott
Biomerieux
Danaher Corporation
F. Hoffmann-La Roche
Becton Dickinson and Company
Bio-Rad Laboratories
Bayer AG
Sysmex Corporation
Johnson & Johnson
Hologic Inc
NEC Corp
Simens Healthcare
Global In Vitro Diagnostics (IVD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Diagnostics (IVD) market, Segment by Type:
Reagents
Instruments
Software and Services
Global In Vitro Diagnostics (IVD) market, by Application
Standalone Laboratory
Hospitals
Academic and Medical Schools
Point of Care Testing
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Diagnostics (IVD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
The global In Vitro Diagnostics (IVD) market size is expected to reach US$ 1530.1 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Diagnostics (IVD) in various end use industries. The expanding demands from the Standalone Laboratory, Hospitals, Academic and Medical Schools and Point of Care Testing, are propelling In Vitro Diagnostics (IVD) market. Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Diagnostics (IVD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Diagnostics (IVD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Diagnostics (IVD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Diagnostics (IVD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Diagnostics (IVD) covered in this report include Pfizer, Thermo Fisher Scientific, Abbott, Biomerieux, Danaher Corporation, F. Hoffmann-La Roche, Becton Dickinson and Company, Bio-Rad Laboratories and Bayer AG, etc.
The global In Vitro Diagnostics (IVD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Thermo Fisher Scientific
Abbott
Biomerieux
Danaher Corporation
F. Hoffmann-La Roche
Becton Dickinson and Company
Bio-Rad Laboratories
Bayer AG
Sysmex Corporation
Johnson & Johnson
Hologic Inc
NEC Corp
Simens Healthcare
Global In Vitro Diagnostics (IVD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Diagnostics (IVD) market, Segment by Type:
Reagents
Instruments
Software and Services
Global In Vitro Diagnostics (IVD) market, by Application
Standalone Laboratory
Hospitals
Academic and Medical Schools
Point of Care Testing
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Diagnostics (IVD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of In Vitro Diagnostics (IVD)
1.1 In Vitro Diagnostics (IVD) Market Overview
1.1.1 In Vitro Diagnostics (IVD) Product Scope
1.1.2 In Vitro Diagnostics (IVD) Market Status and Outlook
1.2 Global In Vitro Diagnostics (IVD) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In Vitro Diagnostics (IVD) Market Size by Region (2018-2029)
1.4 Global In Vitro Diagnostics (IVD) Historic Market Size by Region (2018-2023)
1.5 Global In Vitro Diagnostics (IVD) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In Vitro Diagnostics (IVD) Market Size (2018-2029)
1.6.1 North America In Vitro Diagnostics (IVD) Market Size (2018-2029)
1.6.2 Europe In Vitro Diagnostics (IVD) Market Size (2018-2029)
1.6.3 Asia-Pacific In Vitro Diagnostics (IVD) Market Size (2018-2029)
1.6.4 Latin America In Vitro Diagnostics (IVD) Market Size (2018-2029)
1.6.5 Middle East & Africa In Vitro Diagnostics (IVD) Market Size (2018-2029)
2 In Vitro Diagnostics (IVD) Market by Type
2.1 Introduction
2.1.1 Reagents
2.1.2 Instruments
2.1.3 Software and Services
2.2 Global In Vitro Diagnostics (IVD) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In Vitro Diagnostics (IVD) Historic Market Size by Type (2018-2023)
2.2.2 Global In Vitro Diagnostics (IVD) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In Vitro Diagnostics (IVD) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In Vitro Diagnostics (IVD) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In Vitro Diagnostics (IVD) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In Vitro Diagnostics (IVD) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In Vitro Diagnostics (IVD) Revenue Breakdown by Type (2018-2029)
3 In Vitro Diagnostics (IVD) Market Overview by Application
3.1 Introduction
3.1.1 Standalone Laboratory
3.1.2 Hospitals
3.1.3 Academic and Medical Schools
3.1.4 Point of Care Testing
3.1.5 Others
3.2 Global In Vitro Diagnostics (IVD) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In Vitro Diagnostics (IVD) Historic Market Size by Application (2018-2023)
3.2.2 Global In Vitro Diagnostics (IVD) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In Vitro Diagnostics (IVD) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In Vitro Diagnostics (IVD) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In Vitro Diagnostics (IVD) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In Vitro Diagnostics (IVD) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In Vitro Diagnostics (IVD) Revenue Breakdown by Application (2018-2029)
4 In Vitro Diagnostics (IVD) Competition Analysis by Players
4.1 Global In Vitro Diagnostics (IVD) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Vitro Diagnostics (IVD) as of 2022)
4.3 Date of Key Players Enter into In Vitro Diagnostics (IVD) Market
4.4 Global Top Players In Vitro Diagnostics (IVD) Headquarters and Area Served
4.5 Key Players In Vitro Diagnostics (IVD) Product Solution and Service
4.6 Competitive Status
4.6.1 In Vitro Diagnostics (IVD) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer In Vitro Diagnostics (IVD) Products, Services and Solutions
5.1.4 Pfizer In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Products, Services and Solutions
5.2.4 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott In Vitro Diagnostics (IVD) Products, Services and Solutions
5.3.4 Abbott In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.3.5 Biomerieux Recent Developments
5.4 Biomerieux
5.4.1 Biomerieux Profile
5.4.2 Biomerieux Main Business
5.4.3 Biomerieux In Vitro Diagnostics (IVD) Products, Services and Solutions
5.4.4 Biomerieux In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.4.5 Biomerieux Recent Developments
5.5 Danaher Corporation
5.5.1 Danaher Corporation Profile
5.5.2 Danaher Corporation Main Business
5.5.3 Danaher Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
5.5.4 Danaher Corporation In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.5.5 Danaher Corporation Recent Developments
5.6 F. Hoffmann-La Roche
5.6.1 F. Hoffmann-La Roche Profile
5.6.2 F. Hoffmann-La Roche Main Business
5.6.3 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Products, Services and Solutions
5.6.4 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.6.5 F. Hoffmann-La Roche Recent Developments
5.7 Becton Dickinson and Company
5.7.1 Becton Dickinson and Company Profile
5.7.2 Becton Dickinson and Company Main Business
5.7.3 Becton Dickinson and Company In Vitro Diagnostics (IVD) Products, Services and Solutions
5.7.4 Becton Dickinson and Company In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.7.5 Becton Dickinson and Company Recent Developments
5.8 Bio-Rad Laboratories
5.8.1 Bio-Rad Laboratories Profile
5.8.2 Bio-Rad Laboratories Main Business
5.8.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Products, Services and Solutions
5.8.4 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Rad Laboratories Recent Developments
5.9 Bayer AG
5.9.1 Bayer AG Profile
5.9.2 Bayer AG Main Business
5.9.3 Bayer AG In Vitro Diagnostics (IVD) Products, Services and Solutions
5.9.4 Bayer AG In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer AG Recent Developments
5.10 Sysmex Corporation
5.10.1 Sysmex Corporation Profile
5.10.2 Sysmex Corporation Main Business
5.10.3 Sysmex Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
5.10.4 Sysmex Corporation In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.10.5 Sysmex Corporation Recent Developments
5.11 Johnson & Johnson
5.11.1 Johnson & Johnson Profile
5.11.2 Johnson & Johnson Main Business
5.11.3 Johnson & Johnson In Vitro Diagnostics (IVD) Products, Services and Solutions
5.11.4 Johnson & Johnson In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.11.5 Johnson & Johnson Recent Developments
5.12 Hologic Inc
5.12.1 Hologic Inc Profile
5.12.2 Hologic Inc Main Business
5.12.3 Hologic Inc In Vitro Diagnostics (IVD) Products, Services and Solutions
5.12.4 Hologic Inc In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.12.5 Hologic Inc Recent Developments
5.13 NEC Corp
5.13.1 NEC Corp Profile
5.13.2 NEC Corp Main Business
5.13.3 NEC Corp In Vitro Diagnostics (IVD) Products, Services and Solutions
5.13.4 NEC Corp In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.13.5 NEC Corp Recent Developments
5.14 Simens Healthcare
5.14.1 Simens Healthcare Profile
5.14.2 Simens Healthcare Main Business
5.14.3 Simens Healthcare In Vitro Diagnostics (IVD) Products, Services and Solutions
5.14.4 Simens Healthcare In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2018-2023)
5.14.5 Simens Healthcare Recent Developments
6 North America
6.1 North America In Vitro Diagnostics (IVD) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics (IVD) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics (IVD) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In Vitro Diagnostics (IVD) Market Dynamics
11.1 In Vitro Diagnostics (IVD) Industry Trends
11.2 In Vitro Diagnostics (IVD) Market Drivers
11.3 In Vitro Diagnostics (IVD) Market Challenges
11.4 In Vitro Diagnostics (IVD) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
